Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
DNA sequencing with chain-terminating inhibitors
1977 • 69,181 citations
Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril
1978 • 4,673 citations
Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and Necrosis
1990 • 989 citations
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies.
1987 • 615 citations
Membrane Cofactor Protein (MCP or CD46): Newest Member of the Regulators of Complement Activation Gene Cluster
1991 • 582 citations
Primate erythrocyte-immune complex-clearing mechanism.
1983 • 495 citations
Large scale isolation of functionally active components of the human complement system.
1981 • 446 citations
Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane
1979 • 444 citations
Immunoglobulin gene expression in transformed lymphoid cells.
1983 • 400 citations
Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
1982 • 335 citations
Structure-function relationships of the complement components
1989 • 311 citations
Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19.
1991 • 301 citations
Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity.
1982 • 296 citations
Activation of the alternative complement pathway due to resistance of zymosan-bound.
1977 • 283 citations
Recombinant antibodies possessing novel effector functions
1984 • 282 citations
Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
1988 • 274 citations
Complement receptor is an inhibitor of the complement cascade.
1981 • 267 citations
Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.
1987 • 267 citations
Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.
1984 • 257 citations
Suppression of the Immune Response by a Soluble Complement Receptor of B Lymphocytes
1991 • 242 citations
Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.
1989 • 154 citations
Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection.
1990 • 146 citations
Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.
1991 • 127 citations
A study of the structure of human complement component factor H by Fourier transform infrared spectroscopy and secondary structure averaging methods
1988 • 105 citations
Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex.
1991 • 101 citations
PMA induces the ligand-independent internalization of CR1 on human neutrophils.
1985 • 95 citations
Interaction of iC3b with recombinant isotypic and chimeric forms of CR2.
1991 • 82 citations
Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1.
1988 • 80 citations
Structure-function relationships for the IL-2 receptor system. V. Structure-activity analysis of modified and truncated forms of the Tac receptor protein: site-specific mutagenesis of cysteine residues.
1988 • 37 citations
Reduced activity of DAF on complement enzymes bound to alternative pathway activators. Similarity with Factor H.
1990 • 5 citations